UniProt ID | LRRF2_HUMAN | |
---|---|---|
UniProt AC | Q9Y608 | |
Protein Name | Leucine-rich repeat flightless-interacting protein 2 | |
Gene Name | LRRFIP2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 721 | |
Subcellular Localization | ||
Protein Description | May function as activator of the canonical Wnt signaling pathway, in association with DVL3, upstream of CTNNB1/beta-catenin. Positively regulates Toll-like receptor (TLR) signaling in response to agonist probably by competing with the negative FLII regulator for MYD88-binding.. | |
Protein Sequence | MGTPASGRKRTPVKDRFSAEDEALSNIAREAEARLAAKRAARAEARDIRMRELERQQKEYSLHSFDRKWGQIQKWLEDSERARYSHRSSHHRPYLGVEDALSIRSVGSHRYDMFKDRSSRLSSLNHSYSHSHGMKKRSSDSHKDLLSGLYFDQRNYSSLRHSKPTSAYYTRQSSSLYSDPLATYKSDRASPTANSGLLRSASLASLYNGGLYNPYGPRTPSECSYYSSRISSARSSPGFTNDDTASIVSSDRASRGRRESVVSAADYFSRSNRRGSVVSEVDDISIPDLSSLDEKSDKQYAENYTRPSSRNSASATTPLSGNSSRRGSGDTSSLIDPDTSLSELRDIYDLKDQIQDVEGRYMQGLKELKESLSEVEEKYKKAMVSNAQLDNEKNNLIYQVDTLKDVIEEQEEQMAEFYRENEEKSKELERQKHMCSVLQHKMEELKEGLRQRDELIEEKQRMQQKIDTMTKEVFDLQETLLWKDKKIGALEKQKEYIACLRNERDMLREELADLQETVKTGEKHGLVIIPDGTPNGDVSHEPVAGAITVVSQEAAQVLESAGEGPLDVRLRKLAGEKEELLSQIRKLKLQLEEERQKCSRNDGTVGDLAGLQNGSDLQFIEMQRDANRQISEYKFKLSKAEQDITTLEQSISRLEGQVLRYKTAAENAEKVEDELKAEKRKLQRELRTALDKIEEMEMTNSHLAKRLEKMKANRTALLAQQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MGTPASGRKR -----CCCCCCCCCC | 17.87 | 25367160 | |
8 | Methylation | MGTPASGRKRTPVKD CCCCCCCCCCCCCCC | 23.84 | 115389599 | |
11 | Phosphorylation | PASGRKRTPVKDRFS CCCCCCCCCCCCCCC | 35.15 | 26074081 | |
18 | Phosphorylation | TPVKDRFSAEDEALS CCCCCCCCHHHHHHH | 31.48 | 30266825 | |
25 | Phosphorylation | SAEDEALSNIAREAE CHHHHHHHHHHHHHH | 32.98 | 23403867 | |
80 | Phosphorylation | QKWLEDSERARYSHR HHHHHHHHHHHHCCC | 63.78 | 33259812 | |
85 | Phosphorylation | DSERARYSHRSSHHR HHHHHHHCCCCCCCC | 13.58 | 26074081 | |
88 | Phosphorylation | RARYSHRSSHHRPYL HHHHCCCCCCCCCCC | 28.71 | 19664995 | |
89 | Phosphorylation | ARYSHRSSHHRPYLG HHHCCCCCCCCCCCC | 24.22 | 26074081 | |
96 | Phosphorylation | SHHRPYLGVEDALSI CCCCCCCCHHHCCCC | 18.22 | 32142685 | |
96 (in isoform 2) | Phosphorylation | - | 18.22 | 22617229 | |
99 (in isoform 2) | Phosphorylation | - | 50.86 | 22199227 | |
100 (in isoform 2) | Phosphorylation | - | 6.95 | 22199227 | |
101 (in isoform 2) | Phosphorylation | - | 7.27 | 22199227 | |
102 | Phosphorylation | LGVEDALSIRSVGSH CCHHHCCCCCCCCCC | 20.06 | 26437602 | |
107 (in isoform 2) | Phosphorylation | - | 20.98 | 18669648 | |
108 | Phosphorylation | LSIRSVGSHRYDMFK CCCCCCCCCCCHHCC | 11.57 | 25690035 | |
108 (in isoform 2) | Phosphorylation | - | 11.57 | 25159151 | |
110 (in isoform 2) | Phosphorylation | - | 30.74 | 21406692 | |
111 | Phosphorylation | RSVGSHRYDMFKDRS CCCCCCCCHHCCCCH | 13.31 | - | |
114 | Phosphorylation | GSHRYDMFKDRSSRL CCCCCHHCCCCHHHH | 7.32 | 33259812 | |
115 (in isoform 2) | Phosphorylation | - | 45.66 | 21406692 | |
117 (in isoform 2) | Phosphorylation | - | 36.80 | 21406692 | |
118 | Phosphorylation | YDMFKDRSSRLSSLN CHHCCCCHHHHHHCC | 29.91 | 30576142 | |
119 | Ubiquitination | DMFKDRSSRLSSLNH HHCCCCHHHHHHCCC | 37.83 | 24816145 | |
122 | Phosphorylation | KDRSSRLSSLNHSYS CCCHHHHHHCCCCCH | 31.50 | 27134283 | |
123 | Phosphorylation | DRSSRLSSLNHSYSH CCHHHHHHCCCCCHH | 37.47 | 27134283 | |
128 | Phosphorylation | LSSLNHSYSHSHGMK HHHCCCCCHHCCCCC | 11.67 | - | |
129 | Phosphorylation | SSLNHSYSHSHGMKK HHCCCCCHHCCCCCC | 22.87 | 30576142 | |
130 | Phosphorylation | SLNHSYSHSHGMKKR HCCCCCHHCCCCCCC | 18.64 | 32142685 | |
134 | Ubiquitination | SYSHSHGMKKRSSDS CCHHCCCCCCCCCCC | 3.76 | 24816145 | |
149 | Ubiquitination | HKDLLSGLYFDQRNY HHHHHHHHHCCCCCH | 3.28 | 29967540 | |
152 | Phosphorylation | LLSGLYFDQRNYSSL HHHHHHCCCCCHHHH | 32.73 | 33259812 | |
153 | Ubiquitination | LSGLYFDQRNYSSLR HHHHHCCCCCHHHHC | 26.14 | 24816145 | |
160 | Phosphorylation | QRNYSSLRHSKPTSA CCCHHHHCCCCCCCC | 33.70 | 32645325 | |
168 | Phosphorylation | HSKPTSAYYTRQSSS CCCCCCCCEECCCCC | 12.72 | 30576142 | |
168 (in isoform 5) | Phosphorylation | - | 12.72 | 22617229 | |
169 | Phosphorylation | SKPTSAYYTRQSSSL CCCCCCCEECCCCCC | 8.65 | 30576142 | |
170 | Ubiquitination | KPTSAYYTRQSSSLY CCCCCCEECCCCCCC | 15.00 | 24816145 | |
171 (in isoform 5) | Phosphorylation | - | 20.47 | 22199227 | |
172 | Phosphorylation | TSAYYTRQSSSLYSD CCCCEECCCCCCCCC | 39.61 | 33259812 | |
172 (in isoform 5) | Phosphorylation | - | 39.61 | 22199227 | |
173 | Phosphorylation | SAYYTRQSSSLYSDP CCCEECCCCCCCCCC | 20.71 | 22673903 | |
173 (in isoform 5) | Phosphorylation | - | 20.71 | 22199227 | |
174 | Phosphorylation | AYYTRQSSSLYSDPL CCEECCCCCCCCCCC | 18.94 | 22673903 | |
175 | Phosphorylation | YYTRQSSSLYSDPLA CEECCCCCCCCCCCC | 36.25 | 22673903 | |
177 | Phosphorylation | TRQSSSLYSDPLATY ECCCCCCCCCCCCCC | 16.99 | 24043423 | |
178 | Phosphorylation | RQSSSLYSDPLATYK CCCCCCCCCCCCCCC | 37.74 | 22673903 | |
179 (in isoform 5) | Phosphorylation | - | 28.77 | 18669648 | |
180 | Phosphorylation | SSSLYSDPLATYKSD CCCCCCCCCCCCCCC | 20.25 | 32645325 | |
180 (in isoform 5) | Phosphorylation | - | 20.25 | 25159151 | |
182 (in isoform 5) | Phosphorylation | - | 17.80 | 21406692 | |
183 | Phosphorylation | LYSDPLATYKSDRAS CCCCCCCCCCCCCCC | 38.88 | 22673903 | |
184 | Phosphorylation | YSDPLATYKSDRASP CCCCCCCCCCCCCCC | 11.68 | 24043423 | |
186 | Phosphorylation | DPLATYKSDRASPTA CCCCCCCCCCCCCCC | 23.16 | 26437602 | |
187 (in isoform 5) | Phosphorylation | - | 46.11 | 21406692 | |
188 | Phosphorylation | LATYKSDRASPTANS CCCCCCCCCCCCCCC | 44.02 | 32142685 | |
189 (in isoform 5) | Phosphorylation | - | 25.50 | 21406692 | |
190 | Phosphorylation | TYKSDRASPTANSGL CCCCCCCCCCCCCHH | 24.55 | 21220426 | |
200 | Phosphorylation | ANSGLLRSASLASLY CCCHHHHHHHHHHHH | 23.37 | 21220426 | |
202 | Phosphorylation | SGLLRSASLASLYNG CHHHHHHHHHHHHCC | 26.22 | 21220426 | |
205 | Phosphorylation | LRSASLASLYNGGLY HHHHHHHHHHCCCCC | 36.36 | 21220426 | |
207 | Ubiquitination | SASLASLYNGGLYNP HHHHHHHHCCCCCCC | 14.85 | 24816145 | |
219 | Phosphorylation | YNPYGPRTPSECSYY CCCCCCCCHHHHHCH | 34.01 | - | |
225 | Phosphorylation | RTPSECSYYSSRISS CCHHHHHCHHHCCCC | 21.01 | - | |
231 | Phosphorylation | SYYSSRISSARSSPG HCHHHCCCCCCCCCC | 19.48 | 20044836 | |
232 | Phosphorylation | YYSSRISSARSSPGF CHHHCCCCCCCCCCC | 25.90 | 20044836 | |
235 | Phosphorylation | SRISSARSSPGFTND HCCCCCCCCCCCCCC | 40.37 | - | |
236 | Phosphorylation | RISSARSSPGFTNDD CCCCCCCCCCCCCCC | 24.40 | 20044836 | |
244 | Phosphorylation | PGFTNDDTASIVSSD CCCCCCCCHHHHCCC | 25.76 | 30387612 | |
246 | Phosphorylation | FTNDDTASIVSSDRA CCCCCCHHHHCCCCH | 26.14 | 30387612 | |
249 | Phosphorylation | DDTASIVSSDRASRG CCCHHHHCCCCHHCC | 25.50 | 30576142 | |
250 | Phosphorylation | DTASIVSSDRASRGR CCHHHHCCCCHHCCC | 21.88 | - | |
256 | Ubiquitination | SSDRASRGRRESVVS CCCCHHCCCHHHHHH | 30.42 | 24816145 | |
260 | Phosphorylation | ASRGRRESVVSAADY HHCCCHHHHHHHHHH | 26.47 | 26437602 | |
263 | Phosphorylation | GRRESVVSAADYFSR CCHHHHHHHHHHHHC | 18.64 | 22673903 | |
264 | Ubiquitination | RRESVVSAADYFSRS CHHHHHHHHHHHHCC | 7.86 | 24816145 | |
266 | Phosphorylation | ESVVSAADYFSRSNR HHHHHHHHHHHCCCC | 44.73 | 33259812 | |
267 | Phosphorylation | SVVSAADYFSRSNRR HHHHHHHHHHCCCCC | 9.95 | - | |
271 | Ubiquitination | AADYFSRSNRRGSVV HHHHHHCCCCCCCCE | 33.23 | 24816145 | |
274 | Phosphorylation | YFSRSNRRGSVVSEV HHHCCCCCCCCEEEE | 46.09 | 32645325 | |
276 | Phosphorylation | SRSNRRGSVVSEVDD HCCCCCCCCEEEECC | 19.96 | 26699800 | |
279 | Phosphorylation | NRRGSVVSEVDDISI CCCCCCEEEECCCCC | 29.73 | 26699800 | |
279 | Ubiquitination | NRRGSVVSEVDDISI CCCCCCEEEECCCCC | 29.73 | 24816145 | |
280 | Ubiquitination | RRGSVVSEVDDISIP CCCCCEEEECCCCCC | 38.05 | 24816145 | |
282 | Phosphorylation | GSVVSEVDDISIPDL CCCEEEECCCCCCCH | 43.40 | 32142685 | |
285 | Phosphorylation | VSEVDDISIPDLSSL EEEECCCCCCCHHHC | 34.75 | 30576142 | |
290 | Ubiquitination | DISIPDLSSLDEKSD CCCCCCHHHCCHHHH | 35.91 | 24816145 | |
291 | Phosphorylation | ISIPDLSSLDEKSDK CCCCCHHHCCHHHHH | 47.33 | 24719451 | |
296 | Phosphorylation | LSSLDEKSDKQYAEN HHHCCHHHHHHHHHH | 48.25 | 28796482 | |
298 | Ubiquitination | SLDEKSDKQYAENYT HCCHHHHHHHHHHCC | 52.91 | 24816145 | |
300 | Phosphorylation | DEKSDKQYAENYTRP CHHHHHHHHHHCCCC | 22.94 | 21945579 | |
300 | Ubiquitination | DEKSDKQYAENYTRP CHHHHHHHHHHCCCC | 22.94 | 24816145 | |
304 | Phosphorylation | DKQYAENYTRPSSRN HHHHHHHCCCCCCCC | 8.81 | 21945579 | |
305 | Phosphorylation | KQYAENYTRPSSRNS HHHHHHCCCCCCCCC | 47.92 | 21945579 | |
308 | Phosphorylation | AENYTRPSSRNSASA HHHCCCCCCCCCCCC | 38.34 | 21945579 | |
309 | Phosphorylation | ENYTRPSSRNSASAT HHCCCCCCCCCCCCC | 37.86 | 21945579 | |
311 | Ubiquitination | YTRPSSRNSASATTP CCCCCCCCCCCCCCC | 43.82 | 24816145 | |
312 | Phosphorylation | TRPSSRNSASATTPL CCCCCCCCCCCCCCC | 23.61 | 20044836 | |
314 | Phosphorylation | PSSRNSASATTPLSG CCCCCCCCCCCCCCC | 26.43 | 30266825 | |
314 | Ubiquitination | PSSRNSASATTPLSG CCCCCCCCCCCCCCC | 26.43 | 24816145 | |
315 | Ubiquitination | SSRNSASATTPLSGN CCCCCCCCCCCCCCC | 18.40 | 24816145 | |
316 | Phosphorylation | SRNSASATTPLSGNS CCCCCCCCCCCCCCC | 26.84 | 30266825 | |
317 | Phosphorylation | RNSASATTPLSGNSS CCCCCCCCCCCCCCC | 23.19 | 29255136 | |
320 | Phosphorylation | ASATTPLSGNSSRRG CCCCCCCCCCCCCCC | 36.81 | 29255136 | |
320 | Ubiquitination | ASATTPLSGNSSRRG CCCCCCCCCCCCCCC | 36.81 | 24816145 | |
321 | Ubiquitination | SATTPLSGNSSRRGS CCCCCCCCCCCCCCC | 45.80 | 24816145 | |
323 | Phosphorylation | TTPLSGNSSRRGSGD CCCCCCCCCCCCCCC | 28.84 | 29255136 | |
324 | Phosphorylation | TPLSGNSSRRGSGDT CCCCCCCCCCCCCCH | 29.96 | 29255136 | |
324 | Ubiquitination | TPLSGNSSRRGSGDT CCCCCCCCCCCCCCH | 29.96 | 24816145 | |
326 | Methylation | LSGNSSRRGSGDTSS CCCCCCCCCCCCHHH | 45.65 | 115482331 | |
328 | Phosphorylation | GNSSRRGSGDTSSLI CCCCCCCCCCHHHCC | 31.51 | 29255136 | |
331 | Phosphorylation | SRRGSGDTSSLIDPD CCCCCCCHHHCCCCC | 24.60 | 22167270 | |
332 | Phosphorylation | RRGSGDTSSLIDPDT CCCCCCHHHCCCCCC | 28.08 | 22167270 | |
333 | Phosphorylation | RGSGDTSSLIDPDTS CCCCCHHHCCCCCCC | 31.28 | 22167270 | |
334 | Ubiquitination | GSGDTSSLIDPDTSL CCCCHHHCCCCCCCH | 5.29 | 24816145 | |
335 | Ubiquitination | SGDTSSLIDPDTSLS CCCHHHCCCCCCCHH | 8.58 | 24816145 | |
336 | Ubiquitination | GDTSSLIDPDTSLSE CCHHHCCCCCCCHHH | 40.07 | 24816145 | |
337 | Ubiquitination | DTSSLIDPDTSLSEL CHHHCCCCCCCHHHH | 39.52 | 24816145 | |
339 | Phosphorylation | SSLIDPDTSLSELRD HHCCCCCCCHHHHHH | 36.63 | 30266825 | |
340 | Phosphorylation | SLIDPDTSLSELRDI HCCCCCCCHHHHHHH | 36.96 | 30266825 | |
342 | Phosphorylation | IDPDTSLSELRDIYD CCCCCCHHHHHHHHC | 34.06 | 30266825 | |
345 | Ubiquitination | DTSLSELRDIYDLKD CCCHHHHHHHHCHHH | 24.99 | 24816145 | |
348 | Phosphorylation | LSELRDIYDLKDQIQ HHHHHHHHCHHHHHH | 21.36 | 23403867 | |
348 | Ubiquitination | LSELRDIYDLKDQIQ HHHHHHHHCHHHHHH | 21.36 | 24816145 | |
350 | Ubiquitination | ELRDIYDLKDQIQDV HHHHHHCHHHHHHHH | 3.55 | 24816145 | |
351 | Ubiquitination | LRDIYDLKDQIQDVE HHHHHCHHHHHHHHH | 44.69 | 24816145 | |
355 | Ubiquitination | YDLKDQIQDVEGRYM HCHHHHHHHHHHHHH | 42.96 | 24816145 | |
359 | Ubiquitination | DQIQDVEGRYMQGLK HHHHHHHHHHHHHHH | 26.35 | 24816145 | |
360 | Ubiquitination | QIQDVEGRYMQGLKE HHHHHHHHHHHHHHH | 15.39 | 24816145 | |
365 | Ubiquitination | EGRYMQGLKELKESL HHHHHHHHHHHHHHH | 1.88 | 24816145 | |
370 | Ubiquitination | QGLKELKESLSEVEE HHHHHHHHHHHHHHH | 70.32 | 24816145 | |
379 | Ubiquitination | LSEVEEKYKKAMVSN HHHHHHHHHHHHHHH | 22.47 | 24816145 | |
381 | Ubiquitination | EVEEKYKKAMVSNAQ HHHHHHHHHHHHHHC | 38.33 | 29967540 | |
383 | Sulfoxidation | EEKYKKAMVSNAQLD HHHHHHHHHHHHCCC | 4.69 | 30846556 | |
389 | Ubiquitination | AMVSNAQLDNEKNNL HHHHHHCCCCCCCCC | 7.69 | 24816145 | |
396 | Ubiquitination | LDNEKNNLIYQVDTL CCCCCCCCEEEHHHH | 5.58 | 24816145 | |
398 | Phosphorylation | NEKNNLIYQVDTLKD CCCCCCEEEHHHHHH | 12.97 | 25159151 | |
410 | Ubiquitination | LKDVIEEQEEQMAEF HHHHHHHHHHHHHHH | 46.89 | 24816145 | |
413 | Ubiquitination | VIEEQEEQMAEFYRE HHHHHHHHHHHHHHH | 35.32 | 24816145 | |
420 | Ubiquitination | QMAEFYRENEEKSKE HHHHHHHHCHHHHHH | 58.58 | 24816145 | |
423 | Ubiquitination | EFYRENEEKSKELER HHHHHCHHHHHHHHH | 74.37 | 24816145 | |
433 | Ubiquitination | KELERQKHMCSVLQH HHHHHHHHHHHHHHH | 17.72 | 24816145 | |
444 | Ubiquitination | VLQHKMEELKEGLRQ HHHHHHHHHHHHHHH | 62.74 | 24816145 | |
447 | Ubiquitination | HKMEELKEGLRQRDE HHHHHHHHHHHHHHH | 75.88 | 24816145 | |
454 | Ubiquitination | EGLRQRDELIEEKQR HHHHHHHHHHHHHHH | 54.56 | 24816145 | |
458 | Ubiquitination | QRDELIEEKQRMQQK HHHHHHHHHHHHHHH | 47.71 | 24816145 | |
459 | Ubiquitination | RDELIEEKQRMQQKI HHHHHHHHHHHHHHH | 30.34 | 24816145 | |
464 | Ubiquitination | EEKQRMQQKIDTMTK HHHHHHHHHHHHHHH | 35.02 | 24816145 | |
468 | O-linked_Glycosylation | RMQQKIDTMTKEVFD HHHHHHHHHHHHHHH | 30.16 | 30379171 | |
468 | Phosphorylation | RMQQKIDTMTKEVFD HHHHHHHHHHHHHHH | 30.16 | 20068231 | |
470 | Phosphorylation | QQKIDTMTKEVFDLQ HHHHHHHHHHHHHHH | 26.58 | 30206219 | |
476 | Ubiquitination | MTKEVFDLQETLLWK HHHHHHHHHHHHHHC | 3.17 | 24816145 | |
478 | Ubiquitination | KEVFDLQETLLWKDK HHHHHHHHHHHHCCC | 49.04 | 24816145 | |
479 | Phosphorylation | EVFDLQETLLWKDKK HHHHHHHHHHHCCCC | 17.75 | 30206219 | |
488 | Ubiquitination | LWKDKKIGALEKQKE HHCCCCCCHHHHHHH | 32.75 | 24816145 | |
490 | Ubiquitination | KDKKIGALEKQKEYI CCCCCCHHHHHHHHH | 7.72 | 24816145 | |
495 | Ubiquitination | GALEKQKEYIACLRN CHHHHHHHHHHHHHC | 39.41 | 24816145 | |
505 | Ubiquitination | ACLRNERDMLREELA HHHHCHHHHHHHHHH | 34.00 | 24816145 | |
512 | Ubiquitination | DMLREELADLQETVK HHHHHHHHHHHHHHH | 20.81 | 24816145 | |
522 | Ubiquitination | QETVKTGEKHGLVII HHHHHCCCCCCEEEE | 47.30 | 24816145 | |
524 | Ubiquitination | TVKTGEKHGLVIIPD HHHCCCCCCEEEECC | 30.43 | 24816145 | |
526 | Ubiquitination | KTGEKHGLVIIPDGT HCCCCCCEEEECCCC | 2.21 | 24816145 | |
532 | Ubiquitination | GLVIIPDGTPNGDVS CEEEECCCCCCCCCC | 37.40 | 24816145 | |
541 | Ubiquitination | PNGDVSHEPVAGAIT CCCCCCCCCCCCEEE | 33.68 | 24816145 | |
546 | Ubiquitination | SHEPVAGAITVVSQE CCCCCCCEEEEECHH | 5.64 | 24816145 | |
547 | Ubiquitination | HEPVAGAITVVSQEA CCCCCCEEEEECHHH | 2.69 | 24816145 | |
551 | Phosphorylation | AGAITVVSQEAAQVL CCEEEEECHHHHHHH | 20.26 | 29496963 | |
553 | Ubiquitination | AITVVSQEAAQVLES EEEEECHHHHHHHHH | 38.17 | 24816145 | |
560 | Ubiquitination | EAAQVLESAGEGPLD HHHHHHHHCCCCCHH | 37.10 | 24816145 | |
561 | Ubiquitination | AAQVLESAGEGPLDV HHHHHHHCCCCCHHH | 15.64 | 24816145 | |
562 | Ubiquitination | AQVLESAGEGPLDVR HHHHHHCCCCCHHHH | 50.07 | 24816145 | |
563 | Ubiquitination | QVLESAGEGPLDVRL HHHHHCCCCCHHHHH | 58.30 | 24816145 | |
575 | Ubiquitination | VRLRKLAGEKEELLS HHHHHHHCCHHHHHH | 57.87 | 24816145 | |
576 | Ubiquitination | RLRKLAGEKEELLSQ HHHHHHCCHHHHHHH | 52.25 | 24816145 | |
577 | 2-Hydroxyisobutyrylation | LRKLAGEKEELLSQI HHHHHCCHHHHHHHH | 56.42 | - | |
577 | Acetylation | LRKLAGEKEELLSQI HHHHHCCHHHHHHHH | 56.42 | 26051181 | |
577 | Ubiquitination | LRKLAGEKEELLSQI HHHHHCCHHHHHHHH | 56.42 | 24816145 | |
587 | Ubiquitination | LLSQIRKLKLQLEEE HHHHHHHHHHHHHHH | 4.87 | 24816145 | |
589 | Ubiquitination | SQIRKLKLQLEEERQ HHHHHHHHHHHHHHH | 11.57 | 24816145 | |
604 | Ubiquitination | KCSRNDGTVGDLAGL HHHCCCCCHHHHHHC | 24.95 | 24816145 | |
611 | Ubiquitination | TVGDLAGLQNGSDLQ CHHHHHHCCCCCCCC | 2.73 | 24816145 | |
615 | Phosphorylation | LAGLQNGSDLQFIEM HHHCCCCCCCCCEEH | 42.57 | 27251275 | |
621 | Ubiquitination | GSDLQFIEMQRDANR CCCCCCEEHHHHHHH | 30.47 | 24816145 | |
623 | Ubiquitination | DLQFIEMQRDANRQI CCCCEEHHHHHHHHH | 27.58 | 24816145 | |
625 | Ubiquitination | QFIEMQRDANRQISE CCEEHHHHHHHHHHH | 31.16 | 24816145 | |
638 | Phosphorylation | SEYKFKLSKAEQDIT HHHHHHHCHHHHHHH | 30.34 | 25247763 | |
640 | Ubiquitination | YKFKLSKAEQDITTL HHHHHCHHHHHHHHH | 19.12 | 24816145 | |
645 | Ubiquitination | SKAEQDITTLEQSIS CHHHHHHHHHHHHHH | 33.35 | 24816145 | |
646 | Ubiquitination | KAEQDITTLEQSISR HHHHHHHHHHHHHHH | 28.73 | 24816145 | |
652 | Phosphorylation | TTLEQSISRLEGQVL HHHHHHHHHHHHHHH | 35.74 | 25247763 | |
652 | Ubiquitination | TTLEQSISRLEGQVL HHHHHHHHHHHHHHH | 35.74 | 24816145 | |
659 | Ubiquitination | SRLEGQVLRYKTAAE HHHHHHHHHHHHHHH | 3.68 | 24816145 | |
660 | Ubiquitination | RLEGQVLRYKTAAEN HHHHHHHHHHHHHHH | 31.85 | 24816145 | |
661 | Ubiquitination | LEGQVLRYKTAAENA HHHHHHHHHHHHHHH | 14.45 | 24816145 | |
662 | Ubiquitination | EGQVLRYKTAAENAE HHHHHHHHHHHHHHH | 25.83 | 24816145 | |
675 | Ubiquitination | AEKVEDELKAEKRKL HHHHHHHHHHHHHHH | 11.16 | 24816145 | |
676 | Ubiquitination | EKVEDELKAEKRKLQ HHHHHHHHHHHHHHH | 53.07 | 24816145 | |
699 | Phosphorylation | KIEEMEMTNSHLAKR HHHHHHHHHHHHHHH | 21.91 | 28270605 | |
701 | Phosphorylation | EEMEMTNSHLAKRLE HHHHHHHHHHHHHHH | 15.65 | 28270605 | |
715 | Phosphorylation | EKMKANRTALLAQQ- HHHHHHHHHHHHCC- | 22.82 | 28555341 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRRF2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRRF2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FLII_HUMAN | FLII | physical | 19265123 | |
ATPF2_HUMAN | ATPAF2 | physical | 25416956 | |
CAZA1_HUMAN | CAPZA1 | physical | 26344197 | |
FLII_HUMAN | FLII | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320; SER-324 ANDSER-328, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320; SER-323 ANDSER-324, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment."; Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.; J. Proteome Res. 7:5167-5176(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Quantitative phosphoproteome profiling of Wnt3a-mediated signalingnetwork: indicating the involvement of ribonucleoside-diphosphatereductase M2 subunit phosphorylation at residue serine 20 in canonicalWnt signal transduction."; Tang L.-Y., Deng N., Wang L.-S., Dai J., Wang Z.-L., Jiang X.-S.,Li S.-J., Li L., Sheng Q.-H., Wu D.-Q., Li L., Zeng R.; Mol. Cell. Proteomics 6:1952-1967(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-328, AND MASSSPECTROMETRY. | |
"Unambiguous characterization of site-specific phosphorylation ofleucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-likereceptor 4 (TLR4)-mediated signaling."; Gunawardena H.P., Huang Y., Kenjale R., Wang H., Xie L., Chen X.; J. Biol. Chem. 286:10897-10910(2011). Cited for: PROTEIN SEQUENCE OF 186-218 AND 326-345, PHOSPHORYLATION AT SER-190AND SER-202, MUTAGENESIS OF SER-190; SER-200 AND SER-202, AND MASSSPECTROMETRY. |